Loading…
MeiraGTx Holdings plc is projected to rise to $12.83 by 2027, a +30% move from its current price of $9.89. MGTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.62 | $9.90 | $10.18 | +0.05% |
| May 30 | $9.51 | $9.90 | $10.31 | +0.11% |
| May 31 | $9.43 | $9.91 | $10.41 | +0.16% |
| Jun 1 | $9.36 | $9.91 | $10.50 | +0.22% |
| Jun 2 | $9.30 | $9.92 | $10.57 | +0.27% |
| Jun 3 | $9.25 | $9.92 | $10.64 | +0.33% |
| Jun 4 | $9.20 | $9.93 | $10.71 | +0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.20 | $9.93 | $10.71 | +0.38% |
| Week 2 | $8.95 | $9.97 | $11.09 | +0.76% |
| Week 3 | $8.77 | $10.00 | $11.41 | +1.15% |
| Week 4 | $8.63 | $10.04 | $11.69 | +1.53% |
| Week 5 | $8.51 | $10.08 | $11.94 | +1.92% |
| Week 6 | $8.40 | $10.12 | $12.19 | +2.31% |
| Week 7 | $8.31 | $10.16 | $12.42 | +2.70% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MeiraGTx Holdings plc is a clinical-stage genetic medicines company focused on developing treatments for serious diseases. The company develops a range of therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia.
MeiraGTx Holdings plc (MGTX) is a clinical-stage genetic medicines company. It is currently trading at $9.89 per share. The company has a market capitalization of $915.91M and is ranked 2573 by market cap.
A major floor 29.3% below — a decisive break under it would weaken the trend.
The nearest floor, 9.5% below — buyers have tended to step in here.
The nearest ceiling, 13.8% above — a clean break opens room to run.
A major ceiling 24.7% above — clearing it would confirm fresh momentum.
Key MGTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MGTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.56 | Buy | $9.61 | Buy |
| MA 10 | $9.56 | Buy | $9.58 | Buy |
| MA 20 | $9.59 | Buy | $9.56 | Buy |
| MA 50 | $9.20 | Buy | $9.21 | Buy |
| MA 100 | $8.39 | Buy | $8.76 | Buy |
| MA 200 | $8.26 | Buy | $8.24 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.88 | Neutral |
| Stoch RSI (14) | 86.78 | Sell |
| CCI (20) | 81.16 | Neutral |
| Williams %R (14) | -9.52 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 0.71 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 90.48 | Sell |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 58.58 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 9.58 | Buy |
| ADX (14) | 10.57 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture is bullish with an RSI of 60, indicating positive momentum. The stock trades with a 50-day simple moving average of $9.20 and a 200-day simple moving average of $8.26, suggesting the price is trading above a longer-term trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.99 | $9.89 | $14.16 | 0% | Neutral | |
| $10.12 | $12.83 | $17.25 | +30% | Bullish | |
| $11.57 | $15.09 | $21.06 | +53% | Bullish | |
| $12.37 | $16.52 | $23.75 | +67% | Bullish | |
| $14.71 | $20.07 | $29.57 | +103% | Bullish | |
| $18.80 | $26.16 | $39.39 | +164% | Bullish | |
| $21.41 | $30.34 | $46.58 | +207% | Bullish | |
| $24.05 | $34.67 | $54.19 | +251% | Bullish | |
| $24.24 | $35.52 | $56.43 | +259% | Bullish | |
| $25.00 | $37.22 | $60.02 | +276% | Bullish | |
| $43.09 | $68.87 | $118.36 | +596% | Bullish | |
| $73.49 | $132.95 | $250.62 | +12.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $6.99 | $9.89 | $11.69 | +0.00% |
| June 2026 | $8.83 | $10.39 | $12.51 | +5.01% |
| July 2026 | $8.76 | $10.39 | $12.70 | +0.07% |
| August 2026 | $8.77 | $10.48 | $12.94 | +0.80% |
| September 2026 | $9.07 | $10.90 | $13.58 | +4.05% |
| October 2026 | $9.14 | $11.04 | $13.86 | +1.24% |
| November 2026 | $8.95 | $10.86 | $13.74 | -1.57% |
| December 2026 | $9.13 | $11.12 | $14.16 | +2.40% |
Click any year to see its month-by-month MGTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MGTX price prediction for 2026 points to an average of $9.89 (low $6.99, high $14.16) — a potential gain of 0% on today's $9.89. A consolidation phase looks the most probable path here.
In 2027, MGTX is projected to trade between $10.12 and $17.25, averaging $12.83 — a potential gain of +30% from today's $9.89. That is up +30% on the projected 2026 average. Momentum favours further upside here.
MeiraGTx Holdings plc's 2028 outlook centres on $15.09, within a $11.57 to $21.06 range. That is up +18% on the projected 2027 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, MGTX could reach as high as $23.75, with a base case around $16.52 and support toward $12.37 — roughly +67% from $9.89. Momentum favours further upside here.
Expect MGTX to range from $14.71 to $29.57 through 2030. The $20.07 average target implies a +103% move from current prices. That is up +21% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The MGTX price prediction for 2031 points to an average of $26.16 (low $18.80, high $39.39) — a potential gain of +164% on today's $9.89. Momentum favours further upside here.
In 2032, MGTX is projected to trade between $21.41 and $46.58, averaging $30.34 — a potential gain of +207% from today's $9.89. That is up +16% on the projected 2031 average. Buyers look set to stay in control over this stretch.
MeiraGTx Holdings plc's 2033 outlook centres on $34.67, within a $24.05 to $54.19 range. That is up +14% on the projected 2032 average. That marks a +251% change versus current levels. Momentum favours further upside here.
By 2034, MGTX could reach as high as $56.43, with a base case around $35.52 and support toward $24.24 — roughly +259% from $9.89. Buyers look set to stay in control over this stretch.
Expect MGTX to range from $25.00 to $60.02 through 2035. The $37.22 average target implies a +276% move from current prices. That is up +5% on the projected 2034 average. Momentum favours further upside here.
The MGTX price prediction for 2040 points to an average of $68.87 (low $43.09, high $118.36) — a potential gain of +596% on today's $9.89. Buyers look set to stay in control over this stretch.
In 2050, MGTX is projected to trade between $73.49 and $250.62, averaging $132.95 — a potential gain of +12.4x from today's $9.89. That is up +93% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MGTX today (≈ 101.112235 MGTX) could be worth
$13,443.08
+$12,443.08 (+1244%) by 2050 · US Dollar
Based on the average projected MGTX price of $132.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MGTXwould be worth at today's price.
$1,000 invested in MGTX on May 27, 2025 (≈ 196.463648 MGTX) would be worth
$1,943.03
+$943.03 (+94.3%) today · 1.94× · US Dollar
Based on a MGTX entry price of $5.09 vs. today's $9.89.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.58 | $1,032.36 | +3.2% |
| 1 month ago | $9.13 | $1,083.24 | +8.3% |
| 3 months ago | $7.66 | $1,291.12 | +29.1% |
| 6 months ago | $8.3 | $1,191.57 | +19.2% |
| 1 year ago | $5.09 | $1,943.03 | +94.3% |
| All time (5.0y) ago | $14.73 | $671.42 | -32.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MGTX forecast.
Our base-case forecast reaches $20.00 around 2030.
Implied market cap at $20.00: $1.85B
The multi-year forecast indicates substantial upside after 2026. The 2026 forecast shows a min of $6.99, an avg of $9.89, and a max of $14.16 with an ROI of 0 and a Neutral sentiment. From 2027 onward, the average rises to $12.83 (ROI 29.7, bullish), $15.09 (ROI 52.6, bullish) in 2028, and $16.52 (ROI 67.1, bullish) in 2029.
By 2030, the avg is $20.07 with a 103% ROI and bullish sentiment. The sequence continues to 2031 ($26.16 avg, ROI 164.5), 2032 ($30.34 avg, ROI 206.8), 2033 ($34.67 avg, ROI 250.6), 2034 ($35.52 avg, ROI 259.1), and 2035 ($37.22 avg, ROI 276.3) with bullish sentiment. In 2040, the avg is $68.87 (ROI 596.4) and in 2050, the avg is $132.95 (ROI 1244.3), both with bullish sentiment.
These figures point to a long-term upside potential, though they are estimates and not guarantees. The pipeline spans ocular diseases, neurodegenerative conditions, and other programs, complemented by collaborations with Johnson & Johnson Innovative Medicine and Hologen Limited, potentially supporting future value.
Tap a question to reveal the answer.
The 2030 forecast shows an avg of $20.07 with a min of $14.71 and a max of $29.57, and an ROI of 103%. The sentiment is bullish.
The forecast shows bullish sentiment from 2027 onward, with higher average prices and substantial ROIs by 2030, 2040, and 2050, though these are estimates and not guarantees.
Yes. The 2040 forecast has an avg of $68.87 and the 2050 forecast has an avg of $132.95, with a max of $118.36 in 2040 and a max of $250.62 in 2050, indicating the potential to exceed $100 in the forecast horizon.
Current price is $9.89 and market capitalization is $915.91M.
The 30-day range is $8.19 to $11.95, with a current price of $9.89, RSI 60, SMA50 $9.20, SMA200 $8.26, a support at $8.95 and a resistance at $11.25.
MeiraGTx Holdings plc Community Discussion
0Share your MeiraGTx Holdings plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.